Document Mentions (3 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

isk to keep the business going while we are then analyzing, being aware of and being able to protect our operations." DHS also has a "pretty robust" Continuous Diagnostics and Mitigation "implementation underway, and those cybersecurity tools will feed data about IT assets and access to NOSC's dashboard for display before being sent

le Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Latin America — Tom Lantos Hu

EFTA00148896

2 mentions1 same-page

Page ?Same page

sk to keep the business going while we are then analyzing, being aware of and being able to protect our operations." DHS also has a "pretty robust" Continuous Diagnostics and Mitigation "implementation underway, and those cybersecurity tools will feed data about IT assets and access to NOSC's dashboard for display before being sent

le Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Latin America - Tom Lantos Hu

EFTA01658495

2 mentions1 same-page

Page ?Same page

e Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Latin America - Tom Lantos Hu

Mutual Connections (893)

Entities connected to both Continuous Diagnostics and Mitigation and Novartis U.S. Country

Carter Evans